Back to Search
EMILY STOCKERT, MD
MD
Anesthesiology Physician
NPI: 1992190078IndividualAccepts Medicare
Specialties, Licenses & Credentials
Anesthesiology PhysicianPrimary
Anesthesiology
Code: 207L00000X
A143930(CA)
CMS Specialties
PrimaryANESTHESIOLOGY
Education
UNIVERSITY OF CHICAGO, PRITZKER SCHOOL OF MEDICINE
Class of 2015
Research & Publications (20)
Antibodies specifically targeting a locally misfolded region of tumor associated EGFR.
PMID 19289842·Proc Natl Acad Sci U S A·2009
7-preclinical
Expression of synovial sarcoma X (SSX) antigens in epithelial ovarian cancer and identification of SSX-4 epitopes recognized by CD4+ T cells.
PMID 16428478·Clin Cancer Res·2006
8-other
Treatment of human tumor xenografts with monoclonal antibody 806 in combination with a prototypical epidermal growth factor receptor-specific antibody generates enhanced antitumor activity.
PMID 16144944·Clin Cancer Res·2005
7-preclinical
Immunohistochemical and molecular analysis of human melanomas for expression of the human cancer-testis antigens NY-ESO-1 and LAGE-1.
PMID 15623618·Clin Cancer Res·2004
4-observational
NY-ESO-1 expression and immunogenicity in malignant and benign breast tumors.
PMID 15026363·Cancer Res·2004
8-other
Vaccine-induced CD4+ T cell responses to MAGE-3 protein in lung cancer patients.
PMID 14978137·J Immunol·2004
4-observational
Frequency of NY-ESO-1 and LAGE-1 expression in bladder cancer and evidence of a new NY-ESO-1 T-cell epitope in a patient with bladder cancer.
PMID 14680360·Cancer Immun·2003
8-other
Recombinant antigen expression on yeast surface (RAYS) for the detection of serological immune responses in cancer patients.
PMID 12828452·Cancer Immun·2003
4-observational
Expression and targeting of human fibroblast activation protein in a human skin/severe combined immunodeficient mouse breast cancer xenograft model.
PMID 12939462·Mol Cancer Ther·2003
7-preclinical
NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancer.
PMID 14522938·Cancer Res·2003
8-other
A monoclonal antibody recognizing human cancers with amplification/overexpression of the human epidermal growth factor receptor.
PMID 12515857·Proc Natl Acad Sci U S A·2003
7-preclinical
Antigen-specific immunity in neuroblastoma patients: antibody and T-cell recognition of NY-ESO-1 tumor antigen.
PMID 14583496·Cancer Res·2003
8-other
NY-ESO-1 mRNA expression and immunogenicity in advanced prostate cancer.
PMID 12889868·Cancer Immun·2003
8-other
Antitumor efficacy of cytotoxic drugs and the monoclonal antibody 806 is enhanced by the EGF receptor inhibitor AG1478.
PMID 14676326·Proc Natl Acad Sci U S A·2003
7-preclinical
Identification of a naturally processed NY-ESO-1 peptide recognized by CD8+ T cells in the context of HLA-B51.
PMID 12747757·Cancer Immun·2002
8-other
Cancer-related serological recognition of human colon cancer: identification of potential diagnostic and immunotherapeutic targets.
PMID 12124339·Cancer Res·2002
8-other
Expression of cancer-testis genes in human hepatocellular carcinomas.
PMID 12747756·Cancer Immun·2002
4-observational
CT7 (MAGE-C1) antigen expression in normal and neoplastic tissues.
PMID 12115486·Int J Cancer·2002
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 725 WELCH RD
PALO ALTO, CA 94304 - Phone
- (650) 497-8000
Quick Facts
- NPI
- 1992190078
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 11
- Publications
- 20
Are you this provider?
Claim Your Profile